Nu‑V is a non-surgical laser treatment pathway used at The Women’s Health Clinic for selected vaginal and vulval tissue concerns after assessment.

No. It is a broad consumer term. That is why we focus on symptoms, anatomy, suitability and evidence rather than using the phrase as a diagnosis.

Nu‑V may be discussed for selected concerns such as vaginal dryness, mild laxity, reduced comfort, tissue quality change, mild leakage concerns or changes after childbirth or menopause. Suitability is not automatic.

For genitourinary symptoms of menopause, established options such as vaginal moisturisers, lubricants and vaginal oestrogen should be discussed. Laser may be explored only after careful assessment and informed consent.

No. Laser targets more superficial tissue layers. Surgery, such as vaginoplasty, targets deeper muscle and fascial support. They are different pathways for different concerns.

No. Significant prolapse, deep muscle separation or major structural laxity usually needs specialist assessment and may need pelvic floor physiotherapy or surgical opinion rather than laser.

The Nu‑V treatment itself is typically around 15 minutes, although consultation, assessment, preparation and aftercare discussion are separate.

Some women start with one session; others may be advised to consider a structured course. This depends on symptoms, suitability and goals.

Most women return to gentle daily activities quickly, but mild irritation, spotting, discharge or swelling may occur. You may be advised to avoid intercourse, tampons, swimming, hot baths, heavy lifting and vigorous exercise for a short period.

Possible effects include temporary irritation, swelling, spotting, discharge or discomfort. Rare but more serious risks may include burns, scarring, infection, chronic pain or altered sensation. Risks are discussed before treatment.

Laser may not be suitable during pregnancy or breastfeeding, with active infection, unexplained bleeding, abnormal screening concerns, undiagnosed lesions, significant prolapse, pelvic radiation or mesh history, bleeding disorders or severe pain needing diagnosis first.

Your cervical screening history and any abnormal bleeding or lesion concerns should be reviewed. If screening is overdue, abnormal or clinically concerning, treatment may be delayed pending appropriate assessment.

Evidence is mixed. Some studies and clinical experience report improvements, especially for dryness and comfort, but guideline bodies remain cautious and some sham-controlled trials have shown smaller or non-significant differences. We discuss this honestly at consultation.

Some women who cannot or prefer not to use hormones ask about non-hormonal options. This requires individual medical review, especially after cancer treatment or if local oestrogen is contraindicated or needs specialist input.

A single Nu‑V treatment is £599. A triple package is £1,200. Annual top-up treatment is £400. Please check the pricing page for the latest fees.

Yes. A consultation is important so that symptoms, goals, suitability, alternatives and risks can be properly reviewed before treatment.